indicated that liver X receptors α (LXRα) agonist T0901317 suppressed HCC growth by abrogating TGF-β-induced fibroblastic phenotypes of CAFs and hepatoma cells [42]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.